Morgan and Maideke discuss new medical service to change domains of next medical health to invest a trend

Ali G - Medical Ethics

Shangmusi ·Magenshidanli Asia-Pacific division vice president andStride Dirk director president Mr Zhou Xianghui to meet discuss medical health to invest trend and collaboration

On March 18, 2010 Beijing time 10: 00, the United States Shangmusi ·MorganInvest vice president of administration of fund Asia departmentHu FaxiangGentleman and a half the hour controls communication when striding president of heart gram director Mr Zhou Xianghui to take action, main current the capital square trend that orgnaization of foreign major investment, fund, wind projects science and technology of the medical health that waits to change the China below the circumstance to Chinese cure, medicals and chemical reagents, appliance, new and high biology, healthy medium, healthy management to wait for relevant domain and respect of desire of medical health company undertake, bilateral collaboration reachs consensus;

One: Maideke invests administrative group to have United States of 70% or so medical establishment to appear on the market as home industrial capital runs the health of professional medical health that waits for capital to run experience to support a system business, the demand of enterprise of native land to China medical health is clearer, want to accord with the objective law that at present form and medical health develop, the fund that the long-term strategy in this need invests capital; Hu Zong states at present a lot of wind of foreign are cast begin to recall after the first round of investment, subsequently and those who come is more and rich reason and strategic eye is medium long-term investment bank and professional investment orgnaization, morgan also hopes to pass what He Maide overcomes to recommend with filter, find better medical health to invest an object;

2: Healthy to Chinese medical health industry invests the consensus respect of the standard of select material, basically value a few following types:

1,
Strategic distribution is at present initial finish, and can take significant step screen it is competitor, certain to have brand and the medical health group that own particular market share or medical enterprise;

2,
Have the company of distinctive technology and distinctive profit pattern;

3,
The specialized subject is changed run 3 years of above, but do not be confined to plastic hairdressing, Fu to produce, ophthalmic, additional the specialized subject hospital that the high end such as kind of hairdressing, oral cavity needs a crowd especially, more include burgeoning heart head blood-vessel, heart surgical, orthopaedics, nephrosis, diabetic wait for medical health group;

4,
Have quite the group of dimensions, asset and gain still are had quite dimensions, can coach through striding the major such as Dirk to appear on the market the enterprise that capital requirement accords with after the orgnaization is made;

5,
Innovation domain, have wide market to expand latent capacity, for instance healthy transmission and channel domain, health manages a domain to wait;

6,
Represent national policy if basic level medical health is like mode of community medical health;

7,
New and high science and technology flows like content of chain of biology pharmacy, drug, medical health wait for a domain;

3: Investing means and redound respect can be investment of early days strategy -- appear on the market after the program -- the 2nd round of investment, but do not participate in manage;

The United States Shangmusi ·MorganInvest vice president of administration of fund Asia departmentHu FaxiangDirector president Mr Zhou Xianghui returns gentleman and Maideke undertake be communicationed in detail on item of bilateral and specific collaboration, reach preliminary collaboration intent, both sides states the hope can be happy collaboration;